Schubert, M., Bertoglio, F., Steinke, S., Heine, P. A., Ynga Durand, M. A., Maass, H. ... Hust, M. (2022). Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant. BMC Medicine, 20. (1). doi: 10.1186/s12916-022-02312-5
Schubert, Maren, et al. "Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant." BMC Medicine, vol. 20, no. 1, 2022. https://doi.org/10.1186/s12916-022-02312-5
Schubert, Maren, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga Durand, Henrike Maass, Josè Camilla Sammartino, et al. "Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant." BMC Medicine 20, no. 1 (2022). https://doi.org/10.1186/s12916-022-02312-5
Schubert, M., et al. (2022) 'Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant', BMC Medicine, 20(1). doi: 10.1186/s12916-022-02312-5
Schubert M, Bertoglio F, Steinke S, Heine PA, Ynga Durand MA, Maass H, and sur.. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant. BMC Medicine [Internet]. 2022 March 03 [cited 2024 October 01];20(1). doi: 10.1186/s12916-022-02312-5
M. Schubert, et al., "Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant", BMC Medicine, vol. 20, no. 1, March 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:201199. [Accessed: 01 October 2024]